Interaction and self-organization of human mesenchymal stem cells and neuro-blastoma SH-SY5Y cells under co-culture conditions: A novel system for modeling cancer cell micro-environment

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 76, Issue 2, 2010, Pages 253-259

  Rizvanov, Albert A ^a,b,c   Yalvaç, Mehmet E ^a   Shafigullina, Aygul K ^c   Salafutdinov, Ilnur I ^b   Blatt, Nataliya L ^b   Sahin, Fikrettin ^a   Kiyasov, Andrey P ^c   Palotás, András ^d  

^a YEDITEPE UNIVERSITY   (Turkey)

^b KAZAN FEDERAL UNIVERSITY   (Russian Federation)

^c KAZAN STATE MEDICAL UNIVERSITY   (Russian Federation)

^d Asklepios Med Private Practice and Research Center   (Hungary)

Author keywords

Cancer stem cell; Cell fusion; Co culture; Mesenchymal stem cell; Micro environment; Neuro blastoma

Indexed keywords

ACCURACY; ADOLESCENT; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER TISSUE; CELL FUNCTION; CELL INTERACTION; CELL POPULATION; CELL STRESS; CELL SURFACE; CHILD; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; MICROENVIRONMENT; NEUROBLASTOMA CELL; PARACRINE SIGNALING;

CELL LINE, TUMOR; COCULTURE TECHNIQUES; FLUORESCENCE; HUMANS; MESENCHYMAL STEM CELLS; MODELS, BIOLOGICAL; NEUROBLASTOMA;

EID: 77957287327     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2010.05.012     Document Type: Article

References (22)

1. Boyden S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J. Exp. Med. 1962, 115:453-466.
2. Schichor C., Kerkau S., Visted T., Martini R., Bjerkvig R., Tonn J.C., Goldbrunner R. The brain slice chamber, a novel variation of the Boyden chamber assay, allows time-dependent quantification of glioma invasion into mammalian brain in vitro. J. Neurooncol. 2005, 73:9-18.
3. Valster A., Tran N.L., Nakada M., Berens M.E., Chan A.Y., Symons M. Cell migration and invasion assays. Methods 2005, 37:208-215.
4. Laerum O.D., Nygaar S.J., Steine S., Mork S.J., Engebraaten O., Peraud A., Kleihues P., Ohgaki H. Invasiveness in vitro and biological markers in human primary glioblastomas. J. Neurooncol. 2001, 54:1-8.
5. Oellers P., Schallenberg M., Stupp T., Charalambous P., Senner V., Paulus W., Thanos S. A coculture assay to visualize and monitor interactions between migrating glioma cells and nerve fibers. Nat. Protoc. 2009, 4:923-927.
6. Shoemaker R.H. The NCI60 human tumour cell line anticancer drug screen. Nat. Rev. Cancer 2006, 6:813-823.
7. Padron J.M., van der Wilt C.L., Smid K., Smitskamp-Wilms E., Backus H.H., Pizao P.E., Giaccone G., Peters G.J. The multilayered postconfluent cell culture as a model for drug screening. Crit. Rev. Oncol. Hematol. 2000, 36:141-157.
8. Rhodes L.V., Muir S.E., Elliott S., Guillot L.M., Antoon J.W., Penfornis P., Tilghman S.L., Salvo V.A., Fonseca J.P., Lacey M.R., Beckman B.S., McLachlan J.A., Rowan B.G., Pochampally R., Burow M.E. Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence. Breast Cancer Res. Treat. 2010, 121:293-300.
9. Muehlberg F.L., Song Y.H., Krohn A., Pinilla S.P., Droll L.H., Leng X., Seidensticker M., Ricke J., Altman A.M., Devarajan E., Liu W., Arlinghaus R.B., Alt E.U. Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis 2009, 30:589-597.
10. Mayol J.F., Loeuillet C., Herodin F., Wion D. Characterisation of normal and cancer stem cells: one experimental paradigm for two kinds of stem cells. Bioessays 2009, 31:993-1001.
11. Visvader J.E., Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 2008, 8:755-768.
12. Gupta P.B., Onder T.T., Jiang G., Tao K., Kuperwasser C., Weinberg R.A., Lander E.S. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009, 138:645-659.
13. Yalvac M.E., Ramazanoglu M., Gumru O.Z., Sahin F., Palotás A., Rizvanov A.A. Comparison and optimisation of transfection of human dental follicle cells, a novel source of stem cells, with different chemical methods and electro-poration. Neurochem. Res. 2009, 34:1272-1277.
14. Yalvac M.E., Ramazanoglu M., Rizvanov A.A., Sahin F., Bayrak O.F., Salli U., Palotás A., Kose G.T. Isolation and characterization of stem cells derived from human third molar tooth germs of young adults: implications in neo-vascularization, osteo-, adipo- and neuro-genesis. Pharmacogenomics J. 2010, 10:105-113.
15. Evenson A., Mowschenson P., Wang H., Connolly J., Mendrinos S., Parangi S., Hasselgren P.O. Hyalinizing trabecular adenoma - an uncommon thyroid tumor frequently misdiagnosed as papillary or medullary thyroid carcinoma. Am. J. Surg. 2007, 193:707-712.
16. Smith J., Ladi E., Mayer-Proschel M., Noble M. Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell. Proc. Natl. Acad. Sci. USA 2000, 97:10032-10037.
17. Ito K., Hirao A., Arai F., Matsuoka S., Takubo K., Hamaguchi I., Nomiyama K., Hosokawa K., Sakurada K., Nakagata N., Ikeda Y., Mak T.W., Suda T. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 2004, 431:997-1002.
18. Diehn M., Cho R.W., Lobo N.A., Kalisky T., Dorie M.J., Kulp A.N., Qian D., Lam J.S., Ailles L.E., Wong M., Joshua B., Kaplan M.J., Wapnir I., Dirbas F.M., Somlo G., Garberoglio C., Paz B., Shen J., Lau S.K., Quake S.R., Brown J.M., Weissman I.L., Clarke M.F. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009, 458:780-783.
19. Cheshier S.H., Kalani M.Y., Lim M., Ailles L., Huhn S.L., Weissman I.L. A neurosurgeon's guide to stem cells, cancer stem cells, and brain tumor stem cells. Neurosurgery 2009, 65:237-249.
20. Dittmar T., Nagler C., Schwitalla S., Reith G., Niggemann B., Zanker K.S. Recurrence cancer stem cells - made by cell fusion. Med. Hypotheses 2009, 73:542-547.
21. Creighton C.J., Li X., Landis M., Dixon J.M., Neumeister V.M., Sjolund A., Rimm D.L., Wong H., Rodriguez A., Herschkowitz J.I., Fan C., Zhang X., He X., Pavlick A., Gutierrez M.C., Renshaw L., Larionov A.A., Faratian D., Hilsenbeck S.G., Perou C.M., Lewis M.T., Rosen J.M., Chang J.C. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc. Natl. Acad. Sci. USA 2009, 106:13820-13825.
22. Kaplan R.N., Riba R.D., Zacharoulis S., Bramley A.H., Vincent L., Costa C., MacDonald D.D., Jin D.K., Shido K., Kerns S.A., Zhu Z., Hicklin D., Wu Y., Port J.L., Altorki N., Port E.R., Ruggero D., Shmelkov S.V., Jensen K.K., Rafii S., Lyden D. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005, 438:820-827.